Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Large Cell Neuroendocrine (NE) Tumors

Oncology Center of Biochemical Education And ResearchSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Large Cell Neuroendocrine (NE) Tumors cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Oncology Center of Biochemical Education And Research
Phase 1/2CC
Carboplatin
Oncology Center of Biochemical Education And Research
Phase 1/2CC
Atezolizumab
Oncology Center of Biochemical Education And Research
Phase 1/2CC
RHENIUM RE-188 P2045
University of Maryland, Baltimore
Phase 1/2CC

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →